NIH-funded research NIH-funded research

Apoptotic donor white cells to help kidney transplant tolerance

Official title: Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance

Funded at University of Minnesota · NIH-11311943 · Data updated 2026-11-12

A new approach tests giving a few donor immune cells that are dying off, along with short-term immune drugs, to help kidney transplant patients accept a transplant long-term.

More Transplant research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startApril 20, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$970,873
NIH project number5U19AI174966-04
Project IDNIH-11311943 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with living-donor kidney transplants who could benefit from reduced or tailored immunosuppression.

Less likely to help

Patients with conditions not related to transplant tolerance or those unable to undergo the proposed cell therapies may not benefit.

What this research studies

This project builds on prior work in monkeys showing that two small infusions of donor leukocytes, combined with brief immunosuppression, can create lasting transplant tolerance. In kidney transplant models, researchers will use high‑dimensional immune profiling to understand how the regimen works and to refine the protocol for safety and effectiveness. The study aims to translate these findings into a clinically usable approach that could reduce long-term immunosuppression needs for living donor kidney recipients. The work is conducted at the University of Minnesota with a focus on mechanisms, efficacy, and steps toward human application.

Why it matters

Potential benefit: If successful, this strategy could lead to safer, longer-lasting kidney transplant tolerance with less immunosuppression.

How similar studies have gone: Previous nonhuman primate studies showed durable tolerance; this project seeks to translate that success to a kidney transplant setting.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Hering, Bernhard Josef — University of Minnesota
  • Study coordinator: Hering, Bernhard Josef

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.